Azitra Inc Share Price
AZTRAzitra Inc Stock Performance
Open $0.32 | Prev. Close $0.33 | Circuit Range N/A |
Day Range $0.31 - $0.36 | Year Range $0.26 - $3.90 | Volume 50,185 |
Average Traded $0.33 |
Azitra Inc Share Price Chart
About Azitra Inc
Azitra, Inc., an early-stage clinical biopharmaceutical company, develops therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases. It develops ATR-12, a genetically modified strain of S. epidermidis, which is in Phase Ib clinical trial for treating Netherton syndrome, a skin disease. The company also develops ATR-04, a genetically modified strain of S. epidermidis that is in Phase 1/2 clinical trial for treating the papulopustular rash experienced by cancer patients undergoing epidermal growth factor receptor inhibitor; and ATR-01, an engineered recombinant human filaggrin protein for treating ichthyosis vulgaris, a skin disease. It has a collaboration with Bayer. The company was incorporated in 2014 and is based in Branford, Connecticut.
Azitra Inc Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
16-Jan-26 | $0.32 | $0.32 | -8.07% |
15-Jan-26 | $0.27 | $0.35 | +26.18% |
14-Jan-26 | $0.26 | $0.28 | -1.79% |
13-Jan-26 | $0.29 | $0.28 | -8.20% |
12-Jan-26 | $0.28 | $0.30 | +4.81% |
09-Jan-26 | $0.30 | $0.29 | -3.32% |
08-Jan-26 | $0.30 | $0.30 | +0.33% |